• Rozwój produktu leczniczego
  • Badania kliniczne
  • Jakość
  • Audyty GxP
  • Usługi Rejestracyjne
  • Pharmacovigilance
  • Usługa QP / Import
RFI

MENU

    RFI

    Wyślij do nas wiadomość, skontaktujemy się z Tobą

    Nowości i wydarzenia

    Nowości
    Public consultation on ICH E6(R3) Guideline on good clinical practice (GCP)

    On 26 May 2023, the European Medicines Agency (EMA) published the draft ICH E6 (R3) guideline on good clinical practice (GCP) – step 2b and the template for comments to the ICH E6 (R3) guideline on good clinical practice. The document has been submitted for public consultation and the comments will be collected until September […]

    Dowiedz się więcej
    Nowości
    CEP 2.0 as new certification form issued by EDQM for demonstrating substance used in the preparation of medicinal products compliance with the European Pharmacopoeia

    The CEP, as you know, is a “Certificate of suitability to the monographs of the European Pharmacopoeia“. As we can read on the EDQM (European Directorate for the Quality of Medicines and HealthCare) website it is not mandatory, but the preferred option for demonstrating that a substance used in the preparation of medicinal products complies […]

    Dowiedz się więcej
    RAPS: New FDA Warning Letters Highlight CGMP Deviations at API Plants in China, India

    The US Food and Drug Administration (FDA) on Tuesday released two new warning letters for active pharmaceutical ingredient manufacturers Badrivishal Chemicals & Pharmaceuticals and Lumis Global Pharmaceuticals, both sent 2 March. The letter for Talegaon Dabhade, India-based Badrivishal follows a three-day inspection from last August in which FDA uncovered that the site’s water purification system […]

    Dowiedz się więcej
    EMA: Regulatory cooperation to improve global health

    EMA experts meet with African regulators to discuss opportunities for collaboration. How to improve the availability of high quality, safe and effective medicines to patients in countries beyond Europe and how to make better use of existing tools? These were two of the questions discussed at a workshop jointly organised by the European Medicines Agency […]

    Dowiedz się więcej